Scientific Publications
LCA-0321 is a novel targeted protein degrader designed to specifically and rapidly eliminate TSHR autoantibodies for the treatment of Graves’ disease
American Thyroid Association Annual Meeting 2026
Read MoreSelective degradation of pathogenic autoantibodies by lysosomal targeting chimeras for the treatment of myasthenia gravis
Read MoreCatalytic Degradation of Circulating Targets by FcRn-mediated Cycling LYTACs
Keystone Symposium on Autophagosomes and Endolysosomes 2025
Read MoreMonitoring lysosomal catabolism: a sensitive probe for assessing targeted lysosomal degradation of extracellular proteins
Read MoreLYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
Nature Chemical Biology
Read More